REYLIN SEGURA: Open Payments
NPI 1013240852 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,245 in 132 payments from 35 companies in 2025. Trend: 2023 $3,578 · 2024 $3,454 · 2025 $3,245
Food & beverage: $3,067Education: $178
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $262 |
| Janssen Biotech, Inc. | 8 | $240 |
| Celgene Corporation | 9 | $205 |
| Merck Sharp & Dohme LLC | 7 | $194 |
| Incyte Corporation | 10 | $192 |
| AstraZeneca Pharmaceuticals LP | 6 | $139 |
| Astellas Pharma US Inc | 5 | $122 |
| PFIZER INC. | 8 | $121 |
| Daiichi Sankyo Inc. | 5 | $120 |
| ABBVIE INC. | 4 | $113 |
Products named: SARCLISA, ENHERTU, REBLOZYL, KISQALI, KEYTRUDA, JAKAFI, ERLEADA, Epkinly.
Industry payments across TX — which companies pay providers there.
